MARKET

HBIO

HBIO

Harvard Biosci
NASDAQ
5.25
-0.27
-4.89%
After Hours: 5.40 +0.15 +2.86% 17:41 05/15 EDT
OPEN
5.44
PREV CLOSE
5.52
HIGH
5.48
LOW
5.25
VOLUME
26.45K
TURNOVER
--
52 WEEK HIGH
9.46
52 WEEK LOW
2.813
MARKET CAP
23.68M
P/E (TTM)
-2.3916
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at HBIO last week (0511-0515)?
Weekly Report · 10m ago
Harvard Bioscience Earnings Call Highlights Gradual Recovery
TipRanks · 5d ago
Harvard Bioscience reports Q1 adjusted EPS (33c) vs. ($1.25) last year
TipRanks · 5d ago
Harvard Bioscience reiterates Q2 revenue view $20.5M-$22.5M
TipRanks · 5d ago
Harvard Bioscience reaffirms FY26 revenue growth of 2%-4%
TipRanks · 5d ago
Harvard Bioscience reaffirms 2026 outlook for 2%-4% revenue growth as Project Viking targets $4M annual savings
Seeking Alpha · 5d ago
Harvard Bioscience Unveils Strategic Transformation Toward Translational Tools
TipRanks · 5d ago
Harvard Bioscience Q1 2026 Earnings Call Transcript
Benzinga · 5d ago
More
About HBIO
Harvard Bioscience, Inc. is a developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, drug and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. The Company’s products and services are sold globally to customers ranging from renowned academic institutions and government laboratories to pharmaceutical, biotechnology and contract research organizations (CROs). Its two product categories are cellular and molecular technology (CMT) and Preclinical. Its CMT product family includes the Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS and Warner brands. Its Preclinical product family provides a complete platform to assess physiological data from organisms for research ranging from basic research to drug discovery, and drug development services. The Preclinical Product family includes the DSI, Panlab, Hugo Sachs and Buxco brands.

Webull offers Harvard Bioscience Inc stock information, including NASDAQ: HBIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HBIO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HBIO stock methods without spending real money on the virtual paper trading platform.